Newcastle University has been funded by the Centre for Defence Enterprise (CDE) to develop an effective way to store and transport stem cells.
It has developed alginate hydrogel cell encapsulation technology which allows for the short-term storage and transport at hypothermic temperatures (4-21°C) of wound healing stem cells.
The ‘StemGel’ product offers a viable solution for market demand for therapeutic stem cell transport at cool and ambient temperatures.
The University has also developed a prototype of a stem cell bandage which could be used for advanced wound care therapy for both military and civil benefit.
It’s now seeking funding for commercial development of StemGel and the bandage product.
Dr Che Connon, Professor of Tissue Engineering, Newcastle University says:
CDE funding has meant that we’ve been able to turn an ambitious idea into a physical prototype that’s potentially a massive step forward in realising the commercial potential of cell-based therapies.
CDE funds novel, high-risk, high-potential-benefit research. We work with the broadest possible range of science and technology providers, including academia and small companies, to develop cost-effective capabilities for UK armed forces and national security.
CDE is part of Dstl.